SCHEMBL455180

SCHEMBL455180

O=C1C(=NNC(=S)NC23CC4CC(CC(C4)C2)C3)Nc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.44
EPHX2 P34913 6/20 0.42
FAAH O00519 1/20 0.40
ALDH1A1 P00352 3/20 0.40
HTT P42858 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 2/20 0.40
CNR2 P34972 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.38
ALOX12 P18054 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
TSHR P16473 1/20 0.38
ATM Q13315 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RAB9A P51151 2/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL456344 0.75 KMT2A (0.50) ALDH1A1HTTHPGDLMNAMEN1
SCHEMBL457313 0.75 TDP1 (0.56) ALDH1A1HTTHPGDLMNAMEN1
SCHEMBL458246 0.73 ALDH1A1 (0.49) ALDH1A1HTTKDM4EHPGDLMNA
SCHEMBL2877863 0.72 ALDH1A1 (0.46) ALDH1A1HTTLMNAMEN1KMT2A
SCHEMBL455445 0.72 ALDH1A1 (0.42) ALDH1A1HTTKDM4ELMNAMEN1
SCHEMBL2877739 0.72 MAPT (0.51) ALDH1A1KDM4EHPGDLMNAMEN1
SCHEMBL456638 0.71 MAOA (0.34) ALDH1A1HTTKDM4ELMNAMEN1
SCHEMBL456579 0.71 ALDH1A1 (0.51) ALDH1A1HTTLMNAMEN1KMT2A
SCHEMBL457447 0.71 MAOA (0.34) ALDH1A1HTTKDM4ELMNAMEN1
SCHEMBL455312 0.70 MAPT (0.42) ALDH1A1HTTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
EP-2240175-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) 2010-10-20 EP disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed